RSV vaccine remains effective against distinct viral variants

GSK's Arexvy vaccine for RSV can remain effective against a range of variants and produces strong antibody responses against distinct viral strains.

Related Keywords

Australia ,Anna Frank ,Lionel Sacconnay , ,Science Translational Medicine ,Adult Respiratory Syncytial Virus ,Vaccine ,Mask ,Arexvy ,Respiratory Syncytial Virus ,Rsv ,Drtd ,Svpref3 As01 ,Adjuvant ,Resvi 006 ,Svpref3 ,